搜索临床试验以:HER2-positive GEJ
总计774个结果
-
Mersana Therapeutics招聘中HER2阳性乳腺癌 | HER2阳性胃癌 | HER2阳性非小细胞肺癌 | HER2阳性结直肠癌 | HER2阳性肿瘤 | HER2低位乳腺癌美国
-
Orum Therapeutics USA, Inc.招聘中
-
The First Hospital of Jilin University招聘中
-
The First Affiliated Hospital with Nanjing Medical...招聘中
-
Hallym University Medical Center招聘中
-
National Cancer Center, JapanH.U. Group Research Institute G.K.招聘中
-
First Affiliated Hospital Xi'an Jiaotong University招聘中
-
Jiangsu HengRui Medicine Co., Ltd.招聘中先前接受过曲妥珠单抗和紫杉烷治疗的 HER2 阳性、不可切除和/或转移性乳腺癌受试者中国
-
Odense University HospitalAarhus University Hospital; University of Copenhagen; Aalborg University Hospital招聘中
-
H. Lee Moffitt Cancer Center and Research InstituteVaccinex Inc.招聘中
-
Astellas Pharma Global Development, Inc.招聘中
-
The First Affiliated Hospital of Zhengzhou UniversityBeiGene; Jiangsu Hengrui Pharmaceutical Co., Ltd.; RemeGen Co., Ltd.尚未招聘HER2 阳性或突变的晚期结直肠癌
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.尚未招聘
-
Henan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.招聘中
-
H. Lee Moffitt Cancer Center and Research InstituteImmunoRestoration招聘中
-
First Affiliated Hospital Bengbu Medical College招聘中
-
Henan Cancer HospitalRongchang Biopharmaceutical; Zhengda Tianqing Pharmaceutical Group Co., Ltd.尚未招聘
-
German Breast GroupRoche Pharma AG招聘中
-
Yonsei University尚未招聘
-
iOMEDICO AGSeagen Inc.招聘中
-
Spanish Breast Cancer Research GroupPierre Fabre Laboratories; Puma Biotechnology, Inc.招聘中HER2阳性乳腺癌 | 激素受体阳性 | 早期乳腺癌西班牙
-
The First Affiliated Hospital of Zhengzhou University尚未招聘
-
Criterium, Inc.Novartis; Seagen Inc.招聘中
-
AIPING ZHOU尚未招聘免疫疗法 | 信蒂利单抗 | 局部晚期实体瘤 | 奥沙利铂 | HER2阳性 | 胃或胃食管结合部腺癌 | S-1中国
-
Jiuda ZhaoSecond Hospital of Lanzhou University招聘中
-
Second Affiliated Hospital, School of Medicine,...招聘中
-
Peking University Cancer Hospital & Institute招聘中HER2阳性转移性乳腺癌 | 以前接受过曲妥珠单抗治疗 | 曲妥珠单抗联合帕妥珠单抗和化疗中国
-
Seagen Inc.Merck Sharp & Dohme LLC招聘中HER2阳性乳腺癌美国, 台湾, 加拿大, 大韩民国, 奥地利, 中国, 西班牙, 日本, 法国, 意大利, 瑞士, 澳大利亚, 比利时, 巴西, 德国, 葡萄牙, 英国, 荷兰, 捷克语, 希腊, 智利, 芬兰, 波兰